Alex Nemiroff
Vermögen: 9 Mio $ am 31.05.2026
Vermögen: 9 Mio $ am 31.05.2026
Alex Nemiroff is the founder of RogCon, Inc., established in 2015, holding the title of Chief Executive Officer.
Mr. Nemiroff is the founder of RogCon U.R., Inc., established in 2015, holding the title of Chief Executive Officer.
Mr. Nemiroff currently works at Praxis Precision Medicines, Inc. as Secretary & General Counsel since 2020.
Mr. Nemiroff completed undergraduate education at Stephen M.
Ross School of Business and graduate education at Northwestern University School of Law.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 14.05.2026 | 26.011 ( 0,09 % ) | 9 Mio $ | 31.05.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| PRAXIS PRECISION MEDICINES, INC. | General Counsel | 01.01.2020 |
RogCon, Inc.
RogCon, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company focused on drug research, discovery and development | Vorstandsvorsitzender | 01.11.2015 |
RogCon U.R., Inc. | Vorstandsvorsitzender | 01.11.2015 |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 5 |
|---|---|
Stephen M. Ross School of Business
Stephen M. Ross School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Northwestern University School of Law
Northwestern University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Praxis Precision Medicines, Inc.
Praxis Precision Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company which develops therapies for central nervous system disorders | Health Technology |
RogCon, Inc.
RogCon, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company focused on drug research, discovery and development | Health Technology |
RogCon U.R., Inc. |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen